A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors

NCT01999972 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: axitinib
DRUG: crizotinib
DRUG: axitinib
DRUG: crizotinib
DRUG: axitinib
DRUG: crizotinib

Sponsor

Pfizer